Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides

阅读量：

作者：

T Nongnuj，S Nopparat，A Rhea，K Wongsakorn，K Kessiri，R Zhi，W Li，B Mark，G Wang，H Duane

展开

摘要：

The concurrent increases in global population and sexually transmitted infection (STI) demand a search for agents with dual spermicidal and microbicidal properties for topical vaginal application. Previous attempts to develop the surfactant spermicide, nonoxynol-9 (N-9), into a vaginal microbicide were unsuccessful largely due to its inefficiency to kill microbes. Furthermore, N-9 causes damage to the vaginal epithelium, thus accelerating microbes to enter the women's body. For this reason, antimicrobial peptides (AMPs), naturally secreted by all forms of life as part of innate immunity, deserve evaluation for their potential spermicidal effects. To date, twelve spermicidal AMPs have been described including LL-37, magainin 2 and nisin A. Human cathelicidin LL-37 is the most promising spermicidal AMP to be further developed for vaginal use for the following reasons. First, it is a human AMP naturally produced in the vagina after intercourse. Second, LL-37 exerts microbicidal effects to numerous microbes including those that cause STI. Third, its cytotoxicity is selective to sperm and not to the female reproductive tract. Furthermore, the spermicidal effects of LL-37 have been demonstratedin vivoin mice. Therefore, the availability of LL-37 as a vaginal spermicide/microbicide will empower women for self-protection against unwanted pregnancies and STI.

展开

关键词：

antimicrobial peptide spermicide spermicidal antimicrobial peptide vaginal microbicide vaginal contraceptive sexually transmitted infection vaginitis LL-37 cathelicidin hCAP-18